Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/KK3A stock hub

FRA/KK3A has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/KK3Ais not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

8.1B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/KK3A

In the news

Latest news · FRA/KK3A

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-62.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/KK3A market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

159

Groups with data

Currency

USD

Showing 159 of 159 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	673
Employees Change	75%
Employees Change Percent	17.73
Enterprise value	EUR 8.7B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 8.1B
Price	EUR 62.5
Price currency	EUR
Rev Per Employee	136,364.56x
Sic	2834
Symbol	fra/KK3A
Website	https://www.cytokinetics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.85%
EV Earnings	-12.04x
EV/FCF	-18.19x
EV/Sales	96.35x
FCF yield	-5.86%
P/B ratio	-11.34x
P/S ratio	88.6x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-290.73%
Gross Profit	EUR -266.8M
Net Income	EUR -719.5M
Pretax Margin	-784.02%
Profit Per Employee	EUR -1.1M
ROA	-31.54
Roa5y	-25.94
ROCE	-59.6
ROIC	-62.88

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	24.69%
Cagr15y	17.77%
Cagr1y	117.13%
Cagr3y	20.86%
Cagr5y	26.76%
Revenue Growth	450.6x
Revenue Growth Q	1,125.78x
Revenue Growth3 Y	2.57x
Revenue Growth5 Y	12.56x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.08
Assets	EUR 1.1B
Cash	EUR 709.9M
Current Assets	EUR 711.8M
Current Liabilities	EUR 168.9M
Debt	EUR 1.3B
Debt FCF	EUR -2.63
Equity	EUR -716.9M
Interest Coverage	-5.6
Liabilities	EUR 1.8B
Long Term Assets	EUR 392.7M
Long Term Liabilities	EUR 1.7B
Net Cash	EUR -542.1M
Net Cash By Market Cap	EUR -6.67
Tangible Book Value	EUR -716.9M
Tangible Book Value Per Share	EUR -5.77

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.21
Net Working Capital	EUR -71.9M
Quick ratio	4.14
Working Capital	EUR 555.3M
Working Capital Turnover	EUR 0.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.46%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	808.3%
1Y total return	117.01%
200-day SMA	47.88
3Y total return	76.55%
50-day SMA	54.86
50-day SMA vs 200-day SMA	50over200
5Y total return	227.23%
All Time High	99.5
All Time High Change	-37.19%
All Time High Date	2024-01-09
All Time Low	2.47
All Time Low Change	2,435.5%
All Time Low Date	2014-10-13
ATR	2.5
Ch YTD	19.05
High	62.5
High52	69.44
High52 Date	2026-05-05
High52ch	-9.99%
Low	62.5
Low52	26.2
Low52 Date	2025-05-27
Low52ch	138.55%
Ma50ch	13.93%
Price vs 200-day SMA	30.54%
RSI	68.57
RSI Monthly	62.81
RSI Weekly	70.5
Sharpe ratio	1.31x
Sortino ratio	2.43
Total Return	-4.46%
Tr YTD	19.05
Tr15y	1,062.58%
Tr1m	11.57%
Tr1w	10.89%
Tr3m	19.05%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -555.3M
Operating margin	-605.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	123,879,629%
Net Borrowing	268,037,396.4
Shares Insiders	0.41%
Shares Institutions	113.26%
Shares Qo Q	2.64%
Shares Yo Y	4.46%
Short Ratio	6.25

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -579.4M
Average Volume	48.2x
Bv Per Share	-5.77
CAPEX	EUR -21.7M
Ch10y	808.3
Ch15y	1,062.6
Ch1m	11.57
Ch1w	10.89
Ch1y	117
Ch3m	19.05
Ch3y	76.55
Ch5y	227.2
Ch6m	21.36
Change	-0.83%
Change From Open	0
Close	63.02
Days Gap	-0.83
Depreciation Amortization	9,499,718.3
Earnings Date	2026-05-05
EBIT	EUR -555.3M
EBITDA	EUR -545.6M
EPS	EUR -5.93
F Score	3
FCF	EUR -476.1M
FCF EV Yield	-5.5x
Financing CF	457,478,200
Fiscal Year End	December
Founded	1,997
Investing CF	48,743,995
Is Primary Listing	0
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Date	2013-06-25
Last Split Type	Reverse
Ma150	52.92
Ma150ch	18.1%
Ma20	56.58
Ma20ch	10.46%
Net CF	51,083,103
Open	62.5
Ppne	133,115,618.6
Price Date	2026-05-08
Relative Volume	20x
Revenue	91,773,350x
SBC By Revenue	112.58x
Share Based Comp	103,322,316
Tr6m	21.36%
Volume	0
Z Score	-3.29

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/KK3A pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/KK3A stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/KK3A?

Insider, institutional, and short-interest positioning.

Institutional ownership

+113.3%

Share of float held by funds and institutions

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/KK3A momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

68.6

Neutral momentum band

Price vs 200-day MA

+30.5%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.31

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/KK3A

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/KK3A stock rating?

fra/KK3A is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/KK3A analysis?

The full report lives at /stocks/fra/KK3A/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/KK3A?

The latest report frames fra/KK3A around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/KK3A page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.